Retatrutide is a research peptide designed to activate GLP-1, GIP, and glucagon receptors at the same time. Where most compounds target one or two pathways, RT3 engages all three simultaneously — driving research interest in how combined receptor activation influences metabolic function at a systemic level.
Preclinical investigations have examined its role across:
- Insulin Sensitivity
- Appetite Signaling
- Lipid Metabolism
- Body Composition
- Overall energy balance
Storage Store lyophilized powder at −20°C. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Protect from light and moisture. Avoid freeze-thaw cycles.
Intended Use This product is manufactured exclusively for qualified laboratory research. It is not intended for human or animal use and may not be incorporated into food, supplements, pharmaceuticals, or cosmetic formulations of any kind.
Legal Disclaimer This product has not been reviewed or approved by the U.S. Food and Drug Administration. Grayed makes no representations regarding the diagnosis, treatment, cure, or prevention of any condition or disease.
Terms of Sale By placing an order with GRAYED, the purchaser confirms they are a qualified researcher or authorized entity acting within applicable law. The purchaser assumes full responsibility for safe handling, proper storage, and lawful use of this compound. Due to the nature of our research products and compliance requirements, all sales are final once products are opened. We cannot accept returns of opened or used products.
Reviews
There are no reviews yet.